L. .. Traitements-de-l-'acfa?????????????????????, 22 5.1. Rétablissement et maintien d'un rythme sinusal??????????

.. Prévention-du-risque-embolique and K. , 24 5.3.2. Nouveaux anticoagulants oraux, p.26

.. Description-générale-de-la-population, 39 1.1. Caractéristiques démographiques, ., p.40

.. Et-hémorragique, 51 5.1. Valeur des scores en fonction du traitement antithrombotique recu51 5.2. Risque thromboembolique (score CHA2DS2-VASc) en fonction des patients sous traitement anticoagulant Risque hémorragique (score HAS-BLED) en fonction des patients sous traitement anticoagulant, Les traitements antithrombotiques des patients en fonction des risques thromboembolique, p.52

. Le-deuxième-inconvénient-est-le-risque-hémorragique, Le risque de saignement majeur sous AVK varie de 1 à 13 % par an (43) et augmente beaucoup chez les sujets très âgés. Ce qui explique que les AVK sont la première cause d'hospitalisation pour iatrogénie (65), p.3

. Lorsque-le-risque-thromboembolique-est-Élevé, CHA2DS2-VASc > 6), les patients sont moins traités par anticoagulants : ces patients sont plus fragiles, polypathologiques. Et plus le risque hémorragique est important, moins les patients seront sous anticoagulants

S. S. , H. Cl, and H. Dj, Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study, Heart, vol.86, issue.5, pp.516-537, 2001.

G. As, H. Em, and . Phillips-ka, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, vol.285, issue.18, pp.2370-2375, 2001.

M. Y. Barnes-me, G. Bj, C. Ss, B. Kr, and A. Wp, Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, and implications on the Projections for Future Prevalence, pp.119-125, 1980.

F. Rh, Atrial fibrillation, N Engl J Med, issue.14, pp.344-1067, 2001.

C. Aj, K. P. , and L. Gy, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, vol.31, pp.2369-429, 2010.

K. P. and A. A. Bax, Outcome parameters for trials in atrial fibrillation: executive summary, Eur Heart J, vol.28, issue.22, pp.2803-2820, 2007.

S. S. , H. Cl, and H. Dj, A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, Am J Med, vol.113, issue.5, pp.359-64, 2002.

W. Pa, Atrial Fibrillation as an independent risk factor for stroke: the Framingham study, Stroke, vol.22, pp.983-988, 1991.

L. Gy, Treatment of atrial fibrillation in a district general hospital, Br Heart Journal, vol.71, pp.92-95, 1994.

L. Heuzey, J. , P. O. , P. O. , S. Ma et al., Cost of care distribution in atrial fibrillation patients: the COCAF study, American Heart Journal, vol.147, issue.1, pp.121-126, 2004.
DOI : 10.1016/S0002-8703(03)00524-6

F. V. , R. Le, and C. Ds, guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, Circulation, vol.114, issue.7, pp.257-354, 2006.

W. Dg and W. A. Dimarco-jp, The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM): a comparison of rate control versus rhythm control in patients with atrial fibrillation, N Engl J Med, vol.347, pp.1825-1858, 2002.

H. Em, G. As, and C. Y. , Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, N Engl J Med, vol.349, issue.11, pp.1019-1045, 2003.

H. Rg, B. O. Mcbride, and R. , Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, vol.131, issue.7, pp.492-501, 1999.

H. R. Van-walraven-c and . Singer-de, Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation, JAMA, vol.288, issue.19, pp.2441-2448, 2002.
DOI : 10.1001/jama.288.19.2441

M. J. , H. Fd, and F. K. , Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial, Lancet, vol.370, issue.9586, pp.493-503, 2007.

A. I. , L. Gy, and P. K. , New oral anticoagulant drugs in cardiovascular disease, Thromb Haemost, vol.104, issue.1, pp.49-60

C. Sj, E. Md, and Y. S. , Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, vol.361, pp.1139-51, 2009.

P. Mr, Rivaroxaban versus warfarin in non valvular atrial fibrillation, N Engl J Med, vol.365, issue.10, pp.883-91, 2011.

. Granger, Apixaban versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.11, pp.981-92, 2011.
DOI : 10.1056/NEJMoa1107039

H. Dr, R. V. , and T. Zg, Percutaneous Closure of the left atrial Appendage versus Warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non inferiority trial, Lancet, vol.374, issue.9689, pp.534-576, 2009.

L. Gy, N. R. , and P. R. , Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation, Chest Feb, vol.137, issue.2, pp.263-72, 2010.

L. Gy and F. L. Halperin-jl, Identifying Patients at High Risk for Stroke Despite Anticoagulation. A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort, Stroke, vol.41, issue.12, pp.2731-2739, 2010.

P. R. , L. Da, and N. R. , A novel user-friendly score (HAS- BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest Feb, vol.138, pp.1093-1100, 2010.

G. Bf and Y. Y. Milligan-pe, Clinical Classification Schemes for Predicting Hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), Am Heart J, vol.151, issue.3, pp.713-732, 2006.

F. L. , R. M. , and L. Gy, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 68 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, vol.33, issue.12, pp.1500-1510, 2012.

C. Aj, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2012 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, vol.33, issue.21, pp.2719-2766, 2012.

H. Em, D. , and E. , Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation, Stroke, vol.37, issue.4, pp.1075-80, 2006.

W. J. , W. L. , and V. Ln, Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med, Feb, vol.24, issue.1574, pp.441-446, 1997.

S. Rs and S. De, National patterns of warfarin use in atrial fibrillation, Arch Intern Med, vol.156, issue.22, pp.2537-2578, 1996.

N. R. and C. A. Lip-gy, Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, vol.27, issue.24, pp.3018-3044, 2006.

F. Gc, P. J. , and Y. S. , Cognitive function and anticoagulation control in patients with atrial fibrillation, Circ Cardiovasc Qual Outcomes, vol.3, issue.3, pp.277-83, 2010.

O. Im, Underuse of oral anticoagulants in atrial fibrillation : a systematic review, Am J Med, vol.123, issue.7, pp.638-645, 2010.

R. K. , F. R. , and S. P. Robertson-d, Frailty in elderly people : an evolving concept, CMAJ Feb, vol.15, issue.1504, pp.489-495, 1994.

H. O. and A. P. Belmin, Expert consensus French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people, Archives of cardiovascular diseases, vol.2013, issue.1065, pp.303-326
URL : https://hal.archives-ouvertes.fr/hal-00879721

H. Commission-de-la-transparence, Eliquis dans la FA non valvulaire. 2013, web site : URL : http://www.hassante .fr/portail

M. M. and I. A. Nobili, Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards, Eur J Intern Med, vol.21, issue.6, pp.516-539, 2010.

F. Mc, C. J. , and R. Mw, Atrial fibrillation in the elderly, Am J Med, vol.120, pp.481-488, 2007.

H. Em, Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation, Stroke, vol.37, issue.4, pp.1075-80, 2006.

R. A. Downes-t and P. R. , A randomized controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO), Age and ageing, pp.151-157, 2007.

B. Wl, C. Da, and S. Sd, Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States, J Manag Care Pharm, 2009.

F. P. Miron-e and B. M. , Oral anticoagulants in the elderly, British journal of hematology Feb, vol.120, issue.3, pp.526-534, 2003.

R. Mr, S. J. , and E. V. , Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. The Am J Cardio, Feb, vol.15, issue.974, pp.538-581, 2006.

M. Son-hing-m and N. G. , Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls, Archives of Internal Medicine, vol.159, issue.7, pp.677-85, 1999.
DOI : 10.1001/archinte.159.7.677

G. Cl and C. Tl, Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls, Ann Pharmacother, vol.42, issue.4, pp.523-555, 2008.

P. D. and A. E. Testa-s, Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation, Circulation, vol.124, issue.7, pp.824-833, 2011.

G. A. Estivin-s, Indications of vitamin K antagonists and aspirin in the atrial fibrillation of the elderly, Rev Med Intern, vol.30, issue.8, pp.671-678, 2009.

G. Pk and . Harpe-se, Warfarin use in nursing home residents: results from the 2004 national nursing home survey, Am J Geriatr Pharmacother, vol.10, issue.1, pp.25-36, 2010.